BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11581419)

  • 21. Infectious human papillomavirus type 18 pseudovirions.
    Stauffer Y; Raj K; Masternak K; Beard P
    J Mol Biol; 1998 Oct; 283(3):529-36. PubMed ID: 9784363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and production of fluorescent papillomavirus-like particles.
    Peng S; Zhou J; Frazer IH
    J Tongji Med Univ; 1999; 19(3):170-4, 180. PubMed ID: 12840887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly.
    Li M; Beard P; Estes PA; Lyon MK; Garcea RL
    J Virol; 1998 Mar; 72(3):2160-7. PubMed ID: 9499072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.
    Holmgren SC; Patterson NA; Ozbun MA; Lambert PF
    J Virol; 2005 Apr; 79(7):3938-48. PubMed ID: 15767396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2.
    Heino P; Zhou J; Lambert PF
    Virology; 2000 Oct; 276(2):304-14. PubMed ID: 11040122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early phase in the infection of cultured cells with papillomavirus virions.
    Zhou J; Gissmann L; Zentgraf H; Müller H; Picken M; Müller M
    Virology; 1995 Dec; 214(1):167-76. PubMed ID: 8525612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.
    Laniosz V; Nguyen KC; Meneses PI
    J Virol; 2007 Jul; 81(14):7435-48. PubMed ID: 17475643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions.
    Zhao KN; Hengst K; Liu WJ; Liu YH; Liu XS; McMillan NA; Frazer IH
    Virology; 2000 Jul; 272(2):382-93. PubMed ID: 10873782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.
    Florin L; Becker KA; Sapp C; Lambert C; Sirma H; Müller M; Streeck RE; Sapp M
    J Virol; 2004 Jun; 78(11):5546-53. PubMed ID: 15140951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.
    Kämper N; Day PM; Nowak T; Selinka HC; Florin L; Bolscher J; Hilbig L; Schiller JT; Sapp M
    J Virol; 2006 Jan; 80(2):759-68. PubMed ID: 16378978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smurf2 alters BPV1 trafficking and decreases infection.
    Dabydeen SA; Meneses PI
    Arch Virol; 2011 May; 156(5):827-38. PubMed ID: 21318310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.
    Chandrachud LM; Grindlay GJ; McGarvie GM; O'Neil BW; Wagner ER; Jarrett WF; Campo MS
    Virology; 1995 Aug; 211(1):204-8. PubMed ID: 7544045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.
    Gaukroger JM; Chandrachud LM; O'Neil BW; Grindlay GJ; Knowles G; Campo MS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1577-83. PubMed ID: 8758002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanine exchange factor Vav2: a novel potential target for the development of drugs effective in the prevention of papillomavirus infection and disease.
    Holthusen K; Gonzalez AM; Meneses PI
    Am J Ther; 2009; 16(6):496-507. PubMed ID: 19451809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a discrete intermediate in the assembly/disassembly of physalis mottle tymovirus through mutational analysis.
    Sastri M; Reddy DS; Krishna SS; Murthy MR; Savithri HS
    J Mol Biol; 1999 Jun; 289(4):905-18. PubMed ID: 10369771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.
    Pim D; Broniarczyk J; Bergant M; Playford MP; Banks L
    J Virol; 2015 Oct; 89(20):10145-55. PubMed ID: 26202251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1.
    Zhao KN; Frazer IH
    J Virol; 2002 Dec; 76(23):12265-73. PubMed ID: 12414966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simian virus 40 Vp1 DNA-binding domain is functionally separable from the overlapping nuclear localization signal and is required for effective virion formation and full viability.
    Li PP; Nakanishi A; Shum D; Sun PC; Salazar AM; Fernandez CF; Chan SW; Kasamatsu H
    J Virol; 2001 Aug; 75(16):7321-9. PubMed ID: 11462004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.